Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial
Journal of Clinical Oncology | Feb 06, 2019
Canadian Spontaneous Coronary Artery Dissection cohort study: In-hospital and 30-day outcomes
European Heart Journal | Feb 06, 2019
Gamma-aminobutyric acid receptor type B agonist baclofen inhibits acid-induced excitation of secondary peristalsis but not heartburn sensation
Journal of Gastroenterology and Hepatology | Feb 06, 2019
A randomized, open, controlled trial of tretinoin 0.05% cream vs low-dose oral isotretinoin for the treatment of field cancerization
International Journal of Dermatology | Feb 06, 2019
Four courses vs eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): An open-label, phase 3, non-inferiority, randomised trial
The Lancet: Gastroenterology & Hepatology | Feb 06, 2019
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): An open-label, multicentre, single-arm, phase 3b trial
The Lancet: Gastroenterology & Hepatology | Feb 06, 2019
Natural and synthetic cannabinoids for agitation and aggression in Alzheimer’s disease: A meta-analysis
The Journal of Clinical Psychiatry | Feb 06, 2019
Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT)
Journal of Clinical Oncology | Feb 05, 2019
Efficacy and safety of nivolumab in first-line or further treatment of advanced metastatic biliary tract cancer
Journal of Clinical Oncology | Feb 05, 2019